Fred Tejada - 08 Jul 2026 Form 4 Insider Report for Nu-Med Plus, Inc. (NUMD)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
25 Aug 2026, 17:59:49 UTC
Prior SEC filing
25 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Fred Tejada

Key filing fact

Fred Tejada filed Form 4 for Nu-Med Plus, Inc. (NUMD) on 25 Aug 2026.

Key facts

  • This page summarizes Fred Tejada's Form 4 filing for Nu-Med Plus, Inc. (NUMD).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 25 Aug 2026, 17:59.

Change

  • Previous filing in this sequence was filed on 25 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001552627 Primary reporting owner

TEJADA FRED

Relationship
SVP and Chief Geologist, Director, 10%+ Owner
Address
C/O NU-MED PLUS, INC., 640 BELLE TERRE BUILDING 2E, PORT JEFFERSON, BRITISH COLUMBIA, CANADA
Signature
/s/ Fred Tejada
Signature date
25 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUMD transaction

Common Stock

Other

Transaction value
Shares
+16,381,250
Change %
Price
Shares after
16,381,250
Date
08 Jul 2026
Ownership
Footnote
Footnotes
F1, F2, F3
NUMD transaction

Series X Super Voting Preferred Stock

Award

Transaction value
Shares
+1,000,000
Change %
Price
$0.000000*
Shares after
1,000,000
Date
08 Jul 2026
Ownership
Direct
Footnotes
F4, F5
NUMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
0
Date
08 Jul 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUMD transaction Derivative

Series A Preferred Stock

Award

Transaction value
Shares
+129,782
Change %
Price
Shares after
129,782
Date
08 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,595,640
Exercise price
Footnotes
F6, F7, F8, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Pursuant to a Voting Agreement dated effective July 8, 2026, entered into among the Issuer, the Reporting Person, and certain affiliated stockholders of the Company -- The Hayde Family Revocable Trust dtd 9/21/2001 (trustee: William Hayde, the Company's CEO and a director), Keith Merrell (CFO and a director of the Company, together with his spouse as joint tenants), and Hanover International, Inc. (an entity affiliated with James Hock) (collectively, the "Voting Shareholders"), the Voting Shareholders agreed to vote all Issuer securities beneficially owned or controlled by them in favor of specified matters related to the transactions contemplated by a Share Exchange Agreement, and granted the Reporting Person an irrevocable proxy to vote such shares in accordance with the Voting Agreement in the event the Voting Shareholders fail to do so.

Footnote F2

The Voting Agreement terminates upon the earliest of (i) the tenth anniversary of its execution, (ii) the date the reporting person no longer holds any Company securities, (iii) the date the applicable Voting Shareholder no longer holds any covered shares, or (iv) such earlier date as designated by the Reporting Person.

Footnote F3

As a result of the Voting Agreement, the Reporting Person may be deemed to share voting power over, and to indirectly beneficially own, the shares held by the Voting Shareholders that are subject to the Voting Agreement. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.

Footnote F4

The Series X Preferred Stock votes 100 votes per share, voting together with the common stock (and any other generally-voting class) as a single class on all matters, except as otherwise required by law and has no conversion rights which voting rights are not subject to adjustment in connection with reverse stock splits.

Footnote F5

Issued by the Issuer to the Reporting Person in consideration for services agreed to be rendered as an executive officer of the Issuer.

Footnote F6

Each share of Series A Preferred Stock is convertible into 20 shares of common stock of the Issuer at the option of the holder thereof following the issuance date, which conversion ratio is not subject to adjustment in connection with reverse stock splits.

Footnote F7

Issued to the Reporting Person pursuant to the terms of a June 29, 2026 Share Exchange Agreement between the Issuer, Avid Gold Ltd, a private limited company formed under the laws of England and Wales ("Avid Gold"), and the shareholders of Avid Gold, including the Reporting Person.

Footnote F8

The Series A Preferred Stock has no expiration date.

Footnote F9

The Series A Preferred Stock includes a beneficial ownership limitation that prohibits a holder from converting the Series A Preferred Stock to the extent such conversion would cause the holder, together with its affiliates, to beneficially own more than 4.999% of the Issuer's outstanding common stock, calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended. A holder may elect to increase or decrease this limitation, up to a maximum of 9.999%, by providing written notice to the Issuer, with any increase becoming effective on the 61st day after receipt of such notice.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .